Israel: Market and regulatory data analysis of the cannabis sector

IMC 2022 revenue up 60% as it leaves Canada, focuses on Israel and Germany

Written by Antonia Di Lorenzo | 11th April 2023

International cannabis company IM Cannabis (IMC) reported a significant rise in its revenue for the whole of 2022 as well as the last quarter of the year ...

Cronos sees losses down, net revenue up due to higher sales in Canada and Israel

Written by Antonia Di Lorenzo | 9th March 2023

Canadian cannabis producer Cronos Group saw overall reduced losses for the year, with results helped by sales growth in Canada and Israel but hindered by lower sales in the US ...

Is 2023 the year for the great leap forward on cannabis regulation?

Written by Freddie Dawson | 3rd January 2023

Will 2023 be the year that some fairly major changes start to roll in for cannabis and cannabinoids? It's possible ...

UK scientist says medicinal cannabis research in the country lagging behind

Written by Lorraine Mullaney | 21st October 2022

The UK is lagging behind other major markets in the world on research into the benefits of medicinal cannabis, according to a scientist specialising in the area ...

Israeli cannabis firms expand into Europe, bringing Cookies to Vienna

Written by Lorraine Mullaney | 7th July 2022

Israeli cannabis firm InterCure is collaborating with US brand Cookies to launch Europe’s first flagship Cookies store in Vienna; meanwhile, Panaxia Labs exports to Germany from Malta ...

New studies explore how cannabis can help improve women’s menstrual health

Written by Lorraine Mullaney | 12th May 2022

Clinical trials are investigating how CBD can improve menstrual health and treat conditions such as premenstrual syndrome (PMS) and perhaps even endometriosis ...

Israeli companies predict a bright future in plants following regulatory changes

Written by Lorraine Mullaney | 28th March 2022

Regulatory changes in Israel have enabled a cannabis company to advance breeding methods and grow plants that promise to yield higher levels of cannabinoids ...

More medical applications for cannabinoids being explored

Written by Lorraine Mullaney | 4th March 2022

Scientists around the world are starting to look even further afield for potential uses of cannabis in medical applications, such as treating the symptoms of long Covid-19, Alzheimer’s-related agitation, and to alleviate the pain resulting...

Supply chain hopefuls stay cheerful despite $150m investment fund flop

Written by Lorraine Mullaney | 27th January 2021

Texas-based Collective Growth is remaining positive despite failing to find the right partners for a $150m investment fund raised to develop the US hemp market ...

Researchers suggest CBD could work with terpenes in COVID-19 treatment

Written by CannIntelligence | 14th September 2020

Studies looking at the potential for CBD to treat or alleviate COVID-19 symptoms continue to progress – with one study hinting at promising results combining CBD with other terpene products ...

Multiple proposals could spell legalisation of hemp and CBD in Israel

Written by CannIntelligence | 4th September 2020

Israel is considering amending the Dangerous Drugs Ordinance, which – if successful – will have a major impact on the market with hemp and CBD products ...

The entourage effect – absence of evidence, but no evidence of absence

Written by CannIntelligence | 11th August 2020

Some recent research has cast doubt on the idea that cannabis compounds may be more effective when taken together ...

Distribution deals show faith in future of European CBD retail

Written by Lorraine Mullaney | 22nd July 2020

Firms from Israel and South America are showing faith in the European CBD market, and its bricks-and-mortar retail, with distribution deals to place their products in a growing number of outlets ...

Epidiolex passes another clinical trial for treatment of Dravet syndrome

Written by Freddie Dawson | 11th March 2020

Results from a successful phase three clinical trial on the use of Epidiolex to treat drug-resistant Dravet syndrome have been published in the JAMA Neurology journal ...

Toothpaste giant enters CBD market: business news in brief

Written by CannIntelligence | 26th February 2020

Toothpaste giant Colgate is entering the CBD market, researchers have created a laser scanner that can tell the difference between legal hemp and potentially illegal cannabis, and wrestling legend Kevin Nash has become the latest...

Actor refutes claims he endorsed CBD products: business news in brief

Written by CannIntelligence | 18th February 2020

Tom Hanks refutes false claims over endorsement of CBD products, research suggests cannabinoids benefit gene receptor diseases and CBD coffee is set to hit the market, plus more ...

Can CBD help make anticancer drugs and antibiotics more effective?

Written by Lorraine Mullaney | 22nd January 2020

Two new studies have shown hopeful signs that CBD could be combined with existing drugs to improve treatment – in one case, of cancer, and in the other of the potentially deadly E. coli ...

Research reveals how CBD offsets mentally disturbing effects of THC

Written by CannIntelligence | 17th October 2019

Researchers in Canada have for the first time revealed how CBD can block unwanted THC-related side-effects of cannabis. Also: Can CBD relieve anxiety disorders? and the therapeutic potential of ‘Turbo’ oil tested ...

Trials test link between marijuana and autism: CBD-Intel news in brief

Written by CannIntelligence | 9th October 2019

CBD-Intel brings you business and related news in brief from the US, China, Israel and UK ...

CBD-Intel business news in brief, 19th-23rd August 2019

Written by CannIntelligence | 26th August 2019

Items from China, Thailand, Colombia, Israel, the US, Canada, UK and Ireland include news of the political leader’s son who is planning to open a hemp store, with dad’s blessing ...

CBD-Intel regulatory news in brief, 19th-23rd August 2019

Written by CannIntelligence | 26th August 2019

Austrian and German police policy, local THC decision in Italy, Slovakian de-scheduling, Croatian proposals, US federal and state rulings and Israeli priorities come under the regulatory spotlight ...

CBD-Intel business news in brief, 8th-12th July 2019

Written by CannIntelligence | 15th July 2019

CBD-Intel brings you up-to-date with the latest developments in the fast-moving world of CBD business deals ...

CBD-Intel business news in brief, 1st-5th July 2019

Written by CannIntelligence | 8th July 2019

Elvis Presley CBD for your hound dog? CBD-Intel’s business news round-up includes items from New York, British Columbia, Ireland, the UK, Hong Kong, Israel, Australia and Colombia ...

Israeli and Chinese companies come to an understanding on cannabis

Written by CannIntelligence | 13th May 2019

A new partnership expands Israel’s global cannabis ties and gives a Chinese investor access to an entire portfolio of cannabis and hemp-related start-ups ...

Cannabis is popular left, right and centre as Israeli election approaches

Written by CannIntelligence | 22nd March 2019

Politicians in Israel are rarely united on any single issue, but as the much contended Israeli election draws nearer, members from across the political spectrum support the full legalisation of recreational cannabis ...

Israel can grow its cannabis and CBD sector with government blessing

Written by CannIntelligence | 7th February 2019

Although cannabis is considered a dangerous drug in Israel, government support for cannabis start-ups and liberal policies on research have helped the country develop an active medical cannabis industry ...

Israel gears up for trade after cannabis export law is passed

Written by CannIntelligence | 5th February 2019

Israeli firms will soon be able to export medical cannabis and some derived medical cannabis products after a bill was passed establishing a licensing and supervision regime ...

Kosher product approval achieved by two CBD companies

Written by CannIntelligence | 25th January 2019

Two CBD products have received kosher status from the largest agency in Europe dealing with rabbinically-approved foodstuffs. London-based Advance Biotech received kosher certification from KLBD Kosher Certification in September 2018, followed by Provocan, a CBD brand...

LATEST ALERTS

Written by Antonia Di Lorenzo | 11th April 2023

Written by Antonia Di Lorenzo | 9th March 2023

Written by Freddie Dawson | 3rd January 2023

Written by Lorraine Mullaney | 21st October 2022

Written by Lorraine Mullaney | 7th July 2022

Written by Lorraine Mullaney | 12th May 2022

Written by Lorraine Mullaney | 28th March 2022

Written by Lorraine Mullaney | 4th March 2022

Written by Lorraine Mullaney | 27th January 2021

Written by CannIntelligence | 14th September 2020

Written by CannIntelligence | 4th September 2020

Written by CannIntelligence | 11th August 2020

Written by Lorraine Mullaney | 22nd July 2020

Written by Freddie Dawson | 11th March 2020

Written by CannIntelligence | 26th February 2020

Written by CannIntelligence | 18th February 2020

Written by Lorraine Mullaney | 22nd January 2020

Written by CannIntelligence | 17th October 2019

Written by CannIntelligence | 9th October 2019

Written by CannIntelligence | 26th August 2019

Written by CannIntelligence | 26th August 2019

Written by CannIntelligence | 15th July 2019

Written by CannIntelligence | 8th July 2019

Written by CannIntelligence | 13th May 2019

Written by CannIntelligence | 22nd March 2019

Written by CannIntelligence | 7th February 2019

Written by CannIntelligence | 5th February 2019

Written by CannIntelligence | 25th January 2019

Sign up to our newsletter

Start your FREE trial